← Back to Search

Incentive for Control Condition

N/A
Waitlist Available
Led By Marissa Sharif, PhD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up we will examine a claim for an appointment that was up to 6 months post mailer.
Awards & highlights

Study Summary

This trial will test whether getting a mailing that includes information about how to get help for mental health issues, and why it is important to do so, will increase the number of people who seek out mental health treatment.

Eligible Conditions
  • Control Condition
  • Reward Motivation
  • Hoarding Syndrome
  • Incentive Ineligibility
  • Incentivized Rewards
  • How and Why Incentive Holdout

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~we will examine a claim for an appointment that was up to 6 months post mailer.
This trial's timeline: 3 weeks for screening, Varies for treatment, and we will examine a claim for an appointment that was up to 6 months post mailer. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Appointment Claims 3 Months
Appointment Claims 6 Months
Microwebsite Visits 2 Weeks
+1 more

Trial Design

7Treatment groups
Experimental Treatment
Active Control
Group I: How incentive receiveExperimental Treatment2 Interventions
This will be a group that will receive a mailer emphasizing only how to seek treatment for mental health issues, including an incentive if they seek out mental health treatment (if they visit a therapist within 30 days, they will receive a gift card).
Group II: How incentive ineligibleExperimental Treatment1 Intervention
This will be a group that will receive a mailer emphasizing only how to seek treatment for mental health issues. This group is not eligible for an incentive.
Group III: How incentive holdoutExperimental Treatment1 Intervention
This will be a group that will receive a mailer emphasizing only how to seek treatment for mental health issues. This group is eligible for an incentive but not randomly assigned to it.
Group IV: How and why incentive receiveExperimental Treatment2 Interventions
This will be a group that will receive a mailer emphasizing both how to get help and why they should get help for mental health issues (i.e., listing out how mental health treatment can improve their lives), including an incentive if they seek out mental health treatment (if they visit a therapist within 30 days, they will receive a gift card).
Group V: How and why incentive ineligibleExperimental Treatment1 Intervention
This will be a group that will receive a mailer emphasizing both how to get help and why they should get help for mental health issues (i.e., listing out how mental health treatment can improve their lives). This group is not eligible for an incentive.
Group VI: How and why incentive holdoutExperimental Treatment1 Intervention
This will be a group that will receive a mailer emphasizing both how to get help and why they should get help for mental health issues (i.e., listing out how mental health treatment can improve their lives). This group is eligible for an incentive but not randomly assigned to it.
Group VII: Control ConditionActive Control1 Intervention
Participants in this group will not receive any oureach at all
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
How Nudge
2022
N/A
~60000
How and Why Nudge
2022
N/A
~60000
Incentive
2008
Completed Phase 3
~67070

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,002 Previous Clinical Trials
42,820,999 Total Patients Enrolled
Marissa Sharif, PhDPrincipal InvestigatorUniversity of Pennsylvania
1 Previous Clinical Trials
8,637 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
How v. How and Why Nudges and Rewards
2022. "How v. How and Why Nudges and Rewards". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05376059.
~20571 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top